Total Funding
79
53
Total FundingVenture - Series Unknown raised
Growth Score
2 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
22992
Acorai is a medical device manufacturer of non-invasive intracardiac pressure monitoring to improve heart failure management.
- Filip Peters: CEO & Co-founder
- Jakob Gelberg: CTO & Co-founderPast Role: ClimateHero, CTO
About the Company
Acorai is building a non-invasive heart failure monitoring platform with direct intracardiac pressure monitoring (ICPM) at its core. Acorai offers accurate and cost-efficient heart failure care using patented technology that leverages a novel combination of sensor technologies and machine learning to enable non-invasive ICPM, the only proven way to
improve outcomes in HF patients. The device has been clinically validated, designated FDA Breakthrough Device, and will enter the market in 2025. The company's product can non-invasively monitor cardiac and pulmonary pressure by utilizing machine-learning techniques to analyze pressure dynamics in acoustic, vibratory, and waveform data.
